Table 2 Comparison of characteristics between the PCA groups.

From: Risk factors for discontinuation of intravenous patient-controlled analgesia after general surgery: a retrospective cohort study

Variable

PCA continuation (%), N = 8145

PCA discontinuation (%), N = 600

P value

Age (SD)

60.68 (14.28)

60.35 (14.20)

0.589

Sex, female

3874 (47.56)

427 (71.17)

 < 0.001

LOS after surgery (SD)

7.36 (9.76)

6.21 (4.55)

 < 0.001

Medical history

 DM

719 (8.83)

49 (8.17)

0.581

 HTN

1231 (15.11)

84 (14.00)

0.461

 CKD

207 (2.54)

11 (1.83)

0.283

 Heart disease

253 (3.11)

22 (3.67)

0.448

 Brain disease

217 (2.66)

22 (3.67)

0.146

 Liver disease

613 (7.53)

65 (10.83)

0.003

Anesthesia

0.143

 General anesthesia

8116 (99.64)

600 (100.00)

 

 Spinal anesthesia

29 (0.36)

0 (0.00)

 

ASA physical status classification

0.935

 1

1434 (17.61)

105 (17.50)

 

 2

5199 (63.83)

380 (63.33)

 

 ≥ 3

1512 (18.56)

115 (19.17)

 

Laparoscopy

5400 (66.30)

422 (70.33)

0.043

Type of surgery

0.016

 Stomach

1765 (21.67)

129 (21.50)

 

 Colon

2246 (27.58)

145 (24.17)

 

 Hepato-pancreatic-biliary

1137 (13.96)

107 (17.83)

 

 Breast

951 (11.68)

51 (8.50)

 

 Small bowel

325 (3.99)

32 (5.33)

 

 Transplantation

145 (1.78)

10 (1.67)

 

 Vascular

59 (0.72)

3 (0.50)

 

 Others

1517 (18.62)

123 (20.50)

 

PCA type

0.046

 Opioid included

7723 (94.82)

580 (96.67)

 

 NSAID only

422 (5.18)

20 (3.33)

 

 Background infusion

4093 (50.25)

289 (48.17)

0.002

Preoperative drug usage

 NSAID

420 (5.16)

28 (4.67)

0.599

 Paracetamol

558 (6.85)

30 (5.00)

0.081

 Opioid

614 (7.54)

26 (4.33)

0.004

  1. PCA patient controlled analgesia, SD standard deviation, LOS length of hospital stays, DM diabetes mellitus, HTN hypertension, CKD chronic kidney disease, ASA American Society of Anesthesiologists, PCA patient-controlled analgesia, NSAID non-steroidal anti-inflammatory drug.